Karyopharm Therapeutics, Inc. (KPTI)
8.06
+0.08
(+1.00%)
USD |
NASDAQ |
May 21, 16:00
8.06
0.00 (0.00%)
After-Hours: 19:59
Karyopharm Therapeutics Accounts Payable (Quarterly) : 4.279M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 645.00M |
| Catalyst Pharmaceuticals, Inc. | 7.151M |
| Oncolytics Biotech, Inc. | 0.00 |
| Altimmune, Inc. | 1.53M |
| Cellectar Biosciences, Inc. | 4.725M |